Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119506) titled 'A Real-World Study on the Efficacy and Safety of Ezetimibe Combined with Rosuvastatin in the Treatment of Elderly Patients with ASCVD' on Feb. 28.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Ansteel Group General Hospital
Condition:
Elderly patients with ASCVD
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-01
Target Sample Size: Interventional group:130;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=304516
Published by HT Digital Content Services with permission from Health Daily Dig...